Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria (2023)
- Authors:
- USP affiliated authors: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP ; INACIO, MARIANA CAROLINA BERALDO - FMRP ; PRATA, PEDRO HENRIQUE DE LIMA - FMRP ; CATTO, LUIZ FERNANDO BAZZO - FMRP ; SANTOS, ANDRÉ LUIZ PINTO - FMRP
- Unidade: FMRP
- DOI: 10.1200/JCO.22.00710
- Subjects: ANEMIA; NEOPLASIAS; CÉLULAS MIELOIDES; ESTUDOS TRANSVERSAIS; ESTUDOS RETROSPECTIVOS
- Language: Inglês
- Imprenta:
- Publisher place: Alexandria, VA
- Date published: 2023
- Source:
- Título: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 41, n. 1, p. 132-142, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GURNARI, Carmelo et al. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Journal of Clinical Oncology, v. 41, n. 1, p. 132-142, 2023Tradução . . Disponível em: https://doi.org/10.1200/JCO.22.00710. Acesso em: 23 jan. 2026. -
APA
Gurnari, C., Pagliuca, S., Prata, P. H. de L., Galimard, J. -E., Catto, L. F. B., Larcher, L., et al. (2023). Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria. Journal of Clinical Oncology, 41( 1), 132-142. doi:10.1200/JCO.22.00710 -
NLM
Gurnari C, Pagliuca S, Prata PH de L, Galimard J-E, Catto LFB, Larcher L, Sebert M, Allain V, Santos ALP, Inacio MCB, Calado RT, Socié G, Maciejewski JP. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Journal of Clinical Oncology. 2023 ; 41( 1): 132-142.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1200/JCO.22.00710 -
Vancouver
Gurnari C, Pagliuca S, Prata PH de L, Galimard J-E, Catto LFB, Larcher L, Sebert M, Allain V, Santos ALP, Inacio MCB, Calado RT, Socié G, Maciejewski JP. Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria [Internet]. Journal of Clinical Oncology. 2023 ; 41( 1): 132-142.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1200/JCO.22.00710 - Immunogenetic, molecular and clinical determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria
- IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]
- Molecular international prognostic Scoring System (IPSS-M) in myelodysplastic syndromes arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria
- Determinants of clonal evolution in aplastic anemia
- Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study
- Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
- Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. [Carta]
- Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism. [Carta]: 2022 updated systematic review and meta-analysis of randomized controlled trials
- A review of latest clinical practice guidelines for the management of cancer-associated thrombosis
- Diagnóstico genético, gestão e visualização de dados genômicos de pacientes com síndromes de falência medular hereditária
Informações sobre o DOI: 10.1200/JCO.22.00710 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
